Enquiry form
General enquiries:
+44 (0)207 935 4444
Book a consultation:
+44 (0)207 616 7693
Self-pay enquiry:
+44 (0)203 219 3315
24 April 2020
Cancer care
In the media

The London Clinic, in collaboration with Blood Cancer UK is excited to be participating in the 2.6 Challenge, the nation’s collective effort to support the UK’s charities during the current COVID-19 pandemic.

2.6 Challenge logo

Due to the pandemic, thousands of fundraising events have had to be cancelled, including the Virgin London Marathon which was due to take place on Sunday 26 April. This event alone is one of the world’s biggest one-day fundraising events and it raised more than £66.4m for thousands of charities in 2019.

Many charities have had to reduce or stop services at a time when vulnerable members of society need them most; thousands of staff have been placed on furlough and many charities will not survive the next few months.

Members of staff across The London Clinic, who are already working tirelessly to support urgent care cases as well as supporting the NHS, will be taking time out of their daily schedules to participate in the 2.6k Challenge to have some fun and raise some funds. As a charity, as well as one of the UK’s largest independent hospitals, The London Clinic’s mission is to advance healthcare. Cancer is one of the primary focuses and in order to maintain efforts to beat cancer, particularly during these times, The London Clinic is proud to be working with Blood Cancer UK in pursuit of this shared goal.

Since 1960 Blood Cancer UK has been funding research and providing support to improve blood cancer patients' lives. The London Clinic is working with Blood Cancer UK to support their need to raise awareness of their pioneering work and to generate funds to replenish the shortfall in their revenue, which will be down by £5.6m in 2020.

As well as supporting Blood Cancer UK's research goals, money will also be used to help The London Clinic expand its capacity to collect stem cell donations. Stem cells are increasingly recognised as a powerful way of treating a variety of cancers, in particular blood cancers.

The London Clinic already has the largest stem cell bank in Europe and works closely with other charities including Anthony Nolan and DKMS. Expanding our capacity further will allow The London Clinic to continue to advance healthcare and support Blood Cancer UK’s fight against blood cancers. 

At this time when COVID-19 dominates the daily headlines and all of our thoughts, it’s important to keep wider urgent healthcare issues in mind as well. The 2.6 Challenge can be any activity you like – from running 2.6 miles to holding an online workout with 26 of your friends, or a 26 seconds dance relay.  It's an opportunity to have some fun and we are asking colleagues, friends and family to come together and get involved, to boost morale, raise a smile, some laughter and some urgently needed funds.

 “It is hoped that by supporting our partner charities we will be able to benefit together, as a community, in advancing research, collecting and delivering stem cell donations and providing access to support groups for cancer. Blood Cancer UK is doing pioneering work and we are proud to be collaborating with them at this urgent time.”

Al Russell, Chief Executive, The London Clinic

“The need for Blood Cancer UK’s work has never been greater as people with blood cancer represent the largest group of those most vulnerable to COVID-19. We’re working hard to deliver increased support and information and to protect our research programmes – but all while our fundraising income has dropped off a cliff due to so many cancelled community events across the UK.

Fundraising collaborations such as this one with the staff at The London Clinic means everything to us as a charity and the blood cancer community as it enables our work to continue and raises awareness of the challenges facing our fight to beat blood cancer.

Thank you to the staff at The London Clinic for their understanding, support and fundraising – good luck!”

Gemma Peters, Chief Executive, Blood Cancer UK.”

Share to Twitter Share to Facebook Share to LinkedIn Share to Google Plus